{
  "description": "A CodeSystem to aid NHSBSA in the reimbursment and renumeration process",
  "_filename": "CodeSystem-medicationrequest-endorsement.json",
  "package_name": "uk.nhsdigital.r4",
  "date": "2020-08-24T00:00:00+00:00",
  "publisher": "NHS Digital",
  "content": "complete",
  "name": "NHSBSAPrescriberEndorsements",
  "copyright": "Copyright © 2020 NHS Digital",
  "type": null,
  "experimental": null,
  "resourceType": "CodeSystem",
  "title": null,
  "package_version": "2.5.2",
  "status": "active",
  "id": "e9bcccc9-e87f-40a6-8170-bcc387f55131",
  "kind": null,
  "url": "https://fhir.nhs.uk/CodeSystem/medicationrequest-endorsement",
  "concept": [ {
    "code": "ACBS",
    "display": "Advisory Committee on Borderline Substances",
    "definition": "Prescriptions for products recommended by the Advisory Committee on Borderline Substances."
  }, {
    "code": "AF",
    "display": "Food replacement/food supplement products",
    "definition": "Prescriptions for food replacement/food supplement products available in a variety of flavours"
  }, {
    "code": "CC",
    "display": "Contraceptive",
    "definition": "A drug used for contraceptive purposes which is not listed in Part XVI Section 10 must be endorsed with the female symbol or equivalent"
  }, {
    "code": "FS",
    "display": "Sexual Health",
    "definition": "Any item prescribed for the treatment of an STI must be endorsed with FS by the prescriber in order not to attract a prescription charge"
  }, {
    "code": "SLS",
    "display": "Selected List Scheme",
    "definition": "Drugs and appliances to be prescribed in certain circumstances under the NHS Pharmaceutical Services. The prescriber must endorse the prescription with the reference 'SLS'."
  } ],
  "caseSensitive": true,
  "version": "1.1.0",
  "contact": [ {
    "name": "Interoperability Team",
    "telecom": [ {
      "use": "work",
      "value": "interoperabilityteam@nhs.net",
      "system": "email"
    } ]
  } ]
}